Development and analytical validation of an immunoassay for quantifying serum anti-pertussis toxin antibodies resulting from Bordetella pertussis infection

Clinical and Vaccine Immunology

Volumn 16, Issue 12, 2009, Pages 1781-1788

  Menzies, Sandra L ^a   Kadwad, Vijay ^a,c   Pawloski, Lucia C ^b   Lin, Tsai Lien ^a   Baughman, Andrew L ^b   Martin, Monte ^b   Tondella, Maria Lucia C ^b   Meade, Bruce D ^a,d   Sanden, Gary ^b   Slade, Barbara A ^b   Wilkins, Patricia P ^b   Peters, Jody ^e   Waidmann, Gregory L ^f   Wagner, Leslie ^a   DeVore, Nicolette ^a   Verma, Anita ^a  

^a CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c BRIT   (India)

^d Meade Biologics   (United States)

^e VANDERBILT UNIVERSITY   (United States)

^f School of Public Health   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISERUM; IMMUNOGLOBULIN ANTIBODY; PERTUSSIS TOXIN;

ANALYTIC METHOD; ARTICLE; BLOOD SAMPLING; BORDETELLA PERTUSSIS; CLINICAL EVALUATION; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOASSAY; LABORATORY TEST; PERTUSSIS; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SERODIAGNOSIS; VALIDATION PROCESS; VIRUS REPLICATION; WORLD HEALTH ORGANIZATION;

ANTIBODIES, BACTERIAL; BORDETELLA PERTUSSIS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; IMMUNOGLOBULIN G; PERTUSSIS TOXIN; REAGENT KITS, DIAGNOSTIC; REFERENCE STANDARDS; WHOOPING COUGH;

EID: 73449090818     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00248-09     Document Type: Article

References (39)

1. Andre, P., V. Caro, E. Njamkepo, A. M. Wendelboe, A. Van Rie, and N. Guiso. 2008. Comparison of serological and real-time PCR assays to diagnose Bordetella pertussis infection in 2007. J. Clin. Microbiol. 46:1672-1677.
2. Baughman, A. L., K. M. Bisgard, K. M. Edwards, D. Guris, M. D. Decker, K. Holland, B. D. Meade, and F. Lynn. 2004. Establishment of diagnostic cutoff points for levels of serum antibodies to pertussis toxin, filamentous hemagglutinin, and fimbriae in adolescents and adults in the United States. Clin. Diagn. Lab. Immunol. 11:1045-1053.
3. Baughman, A. L., K. M. Bisgard, F. Lynn, and B. D. Meade. 2006. Mixture model analysis for establishing a diagnostic cut-off point for pertussis antibody levels. Stat. Med. 25:2994-3010.
4. CDC. 2007. Outbreaks of respiratory illness mistakenly attributed to pertussis--New Hampshire, Massachusetts, and Tennessee, 2004-2006. MMWR 56:837-842.
5. CDC. 2006. Preventing tetanus, diphtheria, and pertussis among adolescents: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccines. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm. Rep. 55:1-34.
6. CDC. 2006. Preventing tetanus, diphtheria, and pertussis among adults: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP) and recommendation of ACIP, supported by the Healthcare Infection Control Practices Advisory Committee (HICPAC), for use of Tdap among health-care personnel. MMWR Recomm. Rep. 55:1-37.
7. Cherry, J. D. 2006. Epidemiology of pertussis. Pediatr. Infect. Dis. J. 25:361-362.
8. Cherry, J. D. 2005. The epidemiology of pertussis: a comparison of the epidemiology of the disease pertussis with the epidemiology of Bordetella pertussis infection. Pediatrics 115:1422-1427.
9. de Melker, H. E., F. G. Versteegh, M. A. Conyn-Van Spaendonck, L. H. Elvers, G. A. Berbers, A. van Der Zee, and J. F. Schellekens. 2000. Specificity and sensitivity of high levels of immunoglobulin G antibodies against pertussis toxin in a single serum sample for diagnosis of infection with Bordetella pertussis. J. Clin. Microbiol. 38:800-806.
10. Edwards, K. M. 2005. Overview of pertussis: focus on epidemiology, sources of infection, and long term protection after infant vaccination. Pediatr. Infect. Dis. J. 24:S104-S108.
11. Forsyth, K., M. Nagai, A. Lepetic, and E. Trindade. 2005. Pertussis immunization in the global pertussis initiative international region: recommended strategies and implementation considerations. Pediatr. Infect. Dis. J. 24:S93-S97.
12. Forsyth, K. D., C. H. Wirsing von Konig, T. Tan, J. Caro, and S. Plotkin. 2007. Prevention of pertussis: recommendations derived from the second Global Pertussis Initiative roundtable meeting. Vaccine 25:2634-2642.
13. Fry, N. K., O. Tzivra, Y. T. Li, A. McNiff, N. Doshi, P. A. Maple, N. S. Crowcroft, E. Miller, R. C. George, and T. G. Harrison. 2004. Laboratory diagnosis of pertussis infections: the role of PCR and serology. J. Med. Microbiol. 53:519-525.
14. Giammanco, A., A. Chiarini, P. A. Maple, N. Andrews, R. Pebody, N. Gay, R. M. Olander, F. Fivet-Groyne, S. Baron, A. Tischer, S. Swidsinski, J. Schellekens, and E. Reizenstein. 2003. European Sero-Epidemiology Network: standardisation of the assay results for pertussis. Vaccine 22:112-120.
15. Giammanco, A., A. Nardone, R. Pebody, G. Kafatos, N. Andrews, A. Chiarini, S. Taormina, F. de Ory, K. Prosenc, B. Krize, H. Hallander, M. Ljungman, E. Marva, A. Tsakris, D. O'Flanagan, F. Schneider, A. Griskevicius, R. Vranckx, and I. Karacs. 2008. European Sero-Epidemiology Network 2: standardisation of immunoassay results for pertussis requires homogeneity in the antigenic preparations. Vaccine 26:4486-4493.
16. Guris, D., P. M. Strebel, B. Bardenheier, M. Brennan, R. Tachdjian, E. Finch, M. Wharton, and J. R. Livengood. 1999. Changing epidemiology of pertussis in the United States: increasing reported incidence among adolescents and adults, 1990-1996. Clin. Infect. Dis. 28:1230-1237.
17. Kosters, K., M. Riffelmann, B. Dohrn, and C. H. von Konig. 2000. Comparison of five commercial enzyme-linked immunosorbent assays for detection of antibodies to Bordetella pertussis. Clin. Diagn. Lab. Immunol. 7:422-426.
18. Le, T., J. D. Cherry, S. J. Chang, M. D. Knoll, M. L. Lee, S. Barenkamp, D. Bernstein, R. Edelman, K. M. Edwards, D. Greenberg, W. Keitel, J. Treanor, and J. I. Ward. 2004. Immune responses and antibody decay after immunization of adolescents and adults with an acellular pertussis vaccine: the APERT Study. J. Infect. Dis. 190:535-544.
19. Litt, D. J., D. Samuel, J. Duncan, A. Harnden, R. C. George, and T. G. Harrison. 2006. Detection of anti-pertussis toxin IgG in oral fluids for use in diagnosis and surveillance of Bordetella pertussis infection in children and young adults. J. Med. Microbiol. 55:1223-1228.
20. Lynn, F., G. F. Reed, and B. D. Meade. 1996. Collaborative study for the evaluation of enzyme-linked immunosorbent assays used to measure human antibodies to Bordetella pertussis antigens. Clin. Diagn. Lab. Immunol. 3:689-700.
21. Mandel, J. 1991. Evaluation and control of measurements. Marcel Dekker, Inc., New York, NY.
22. Mandel, J. 1991. The validation of measurement through interlaboratory studies. Chemom. Intell. Lab. Syst. 11:109-119.
23. Marchant, C. D., A. M. Loughlin, S. M. Lett., C. W. Todd, L. H. Wetterlow, R. Bicchieri, S. Higham, P. Etkind, E. Silva, and G. R. Siber. 1994. Pertussis in Massachusetts, 1981-1991: incidence, serologic diagnosis, and vaccine effectiveness. J. Infect. Dis. 169:1297-1305.
24. Mattoo, S., and J. D. Cherry. 2005. Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies. Clin. Microbiol. Rev. 18:326-382.
25. Meade, B. D., A. Deforest, K. M. Edwards, T. A. Romani, F. Lynn, C. H. O'Brien, C. B. Swartz, G. F. Reed, and M. A. Deloria. 1995. Description and evaluation of serologic assays used in a multicenter trial of acellular pertussis vaccines. Pediatrics 96:570-575.
26. Prince, H. E., M. Lape-Nixon, and J. Matud. 2006. Evaluation of a tetraplex microsphere assay for Bordetella pertussis antibodies. Clin. Vaccine Immunol. 13:266-270.
27. Reder, S., M. Riffelmann, C. Becker, and C. H. Wirsing von Konig. 2008. Measuring immunoglobulin G antibodies to tetanus toxin, diphtheria toxin, and pertussis toxin with single-antigen enzyme-linked immunosorbent assays and a bead-based multiplex assay. Clin. Vaccine Immunol. 15:744-749.
28. Riffelmann, M., M. Littmann, C. Hulsse, and C. H. von Konig. 2009. Antibody decay after immunisation of health-care workers with an acellular pertussis vaccine. Eur. J. Clin. Microbiol. Infect. Dis. 28:275-279.
29. Riffelmann, M., C. H. Wirsing von Konig, V. Caro, and N. Guiso. 2005. Nucleic acid amplification tests for diagnosis of Bordetella infections. J. Clin. Microbiol. 43:4925-4929.
30. Rothstein, E., and K. Edwards. 2005. Health burden of pertussis in adolescents and adults. Pediatr. Infect. Dis. J. 24:S44-S47.
31. Tatti, K. M., K. H. Wu, M. L. Tondella, P. K. Cassiday, M. M. Cortese, P. P. Wilkins, and G. N. Sanden. 2008. Development and evaluation of dual-target real-time polymerase chain reaction assays to detect Bordetella spp. Diagn. Microbiol. Infect. Dis. 61:264-272.
32. Tondella, M. L., G. M. Carlone, N. Messonnier, C. P. Quinn, B. D. Meade, D. L. Burns, J. D. Cherry, N. Guiso, E. L. Hewlett, K. M. Edwards, D. Xing, A. Giammanco, C. H. Wirsing von Konig, L. Han, L. Hueston, J. B. Robbins, M. Powell, C. M. Mink, J. T. Poolman, S. W. Hildreth, F. Lynn, and A. Morris. 2009. International Bordetella pertussis assay standardization and harmonization meeting report. Centers for Disease Control and Prevention, Atlanta, Georgia, United States, 19-20 July 2007. Vaccine 27:803-814.
33. Trollfors, B., T. Lagergard, E. Gunnarsson, and J. Taranger. 2003. Determination of pertactin IgG antibodies for the diagnosis of pertussis. Clin. Microbiol. Infect. 9:585-589.
34. van Gageldonk, P. G., F. G. van Schaijk, F. R. van der Klis, and G. A. Berbers. 2008. Development and validation of a multiplex immunoassay for the simultaneous determination of serum antibodies to Bordetella pertussis, diphtheria and tetanus. J. Immunol. Methods 335:79-89.
35. Watanabe, M., B. Connelly, and A. A. Weiss. 2006. Characterization of serological responses to pertussis. Clin. Vaccine Immunol. 13:341-348.
36. Wendelboe, A. M., and A. Van Rie. 2006. Diagnosis of pertussis: a historical review and recent developments. Expert Rev. Mol. Diagn. 6:857-864.
37. Wirsing von Konig, C. H., D. Gounis, S. Laukamp, H. Bogaerts, and H. J. Schmitt. 1999. Evaluation of a single-sample serological technique for diagnosing pertussis in unvaccinated children. Eur. J. Clin. Microbiol. Infect. Dis. 18:341-345.
38. Wirsing von Konig, C. H., S. Halperin, M. Riffelmann, and N. Guiso. 2002. Pertussis of adults and infants. Lancet Infect. Dis. 2:744-750.
39. Xing, D., C. H. Wirsing von Konig, P. Newland, M. Riffelmann, B. D. Meade, M. Corbel, and R. Gaines-Das. 2009. Characterization of reference materials for human antiserum to pertussis antigens by an international collaborative study. Clin. Vaccine Immunol. 16:303-311.